Q4 & FY22 Highlights

Investment Highlights Largest consumer healthcare brand in diagnostic services, with unmatched reputation Demonstrated high scalability, integrated through centralized IT platform for network expansion Best-in-class and consistent financial track record with healthy return ratios Brand Well poised to garner incremental market share centered on intrinsic strengths and expertise in healthcare Consolidating presence in West through Suburban acquisition Fundamental levers in place to drive expansion based on humongous market opportunity Classification: Restricted 10 Dr Lal PathLabs

View entire presentation